ANN ARBOR STAGE IV FOLLICULAR LYMPHOMA
Clinical trials for ANN ARBOR STAGE IV FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE IV FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE IV FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug cocktail aims to boost remission in follicular lymphoma
Disease control Recruiting nowThis phase 2 trial tests a combination of three drugs—zanubrutinib, rituximab, and venetoclax—in people with previously untreated follicular lymphoma. The goal is to see if this mix can improve the rate of complete remission (disappearance of cancer). Participants receive all thr…
Matched conditions: ANN ARBOR STAGE IV FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a lower dose of this antibody tame Slow-Growing lymphoma?
Disease control Recruiting nowThis phase II trial is testing whether a low dose of the drug mosunetuzumab can safely and effectively treat people with slow-growing B-cell lymphomas, like follicular and marginal zone lymphoma. The study will enroll 20 adults who have not had prior lymphoma therapy and have low…
Matched conditions: ANN ARBOR STAGE IV FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC